Accreditation Information

Target Audience

This activity is intended for physicians and PAs engaged in the care of patients with CIC, IBS-C, and IBS-D.

This activity is intended for physicians and PAs delivering primary care to adolescents and adults.

This activity is intended for physicians and PAs engaged in care of patients with CIC, IBS-C, and IBS-D in the primary care setting.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Differentiate between IBS-C, CIC, and other conditions that present with similar symptoms.
  • Describe the diagnostic criteria of IBS-C, IBS-D, and CIC.
  • Describe the effect of CIC, IBS-C, and IBS-D on patient QOL and develop a plan to address these issues.
  • Compare new and emerging treatment options for patients with CIC and IBS-C to develop a holistic treatment approach.
  • Discuss current and emerging treatment options for patients with IBS-D.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBmed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistant Continuing Education

This program has been reviewed and is approved for a maximum of 1.5 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Approval is valid for 2 years from the issue date of June 29, 2017. Participants may submit the self-assessment at any time during that period. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Name of Faculty or Presenter Reported Financial Relationship
Nimish Vakil, MD, FACP, FACG, AGAF, FASGE Consulting fees: Allergan and Ironwood Pharmaceuticals
Kimberly Carter, MPAS, PA-C Has no real or apparent conflict of interest

The planners and Managers

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. The DKB planners and managers, have nothing to disclose.

Method of Participation and Request for Credit

There are no fees for participating in this CME activity. During the period June 29, 2017 through June 28, 2018, to receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Participants must attest to the amount of time they spent on the activity.

Successful completion of the post-test is required to earn AMA or AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70% percent correct. Your certificate will be made available immediately.

Media: Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Release date: June 29, 2017
Expiration date: June 28, 2019
Estimated time to complete activity: 1.5 hours
Copyright © 2017. ODM: IBS
Presented by PIM in collaboration with DKBmed

PC: Internet Explorer (v9 or greater), Chrome or Firefox
MAC: Safari
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.